Epilepsy is well-recognized as a disorder of brain networks. There is a growing body of
research to identify critical nodes within dynamic epileptic networks with the aim to target …

Background Vagus nerve stimulation (VNS) is approved as an adjunctive treatment for drug-
resistant epilepsy. Although there is a substantial amount of literature aiming at unraveling …

Background Dysfunction of the thalamocortical connectivity network is thought to underlie
the pathophysiology of the migraine. This current study aimed to explore the thalamocortical …

The vagus nerve stimulation (VNS) Therapy® System is the first FDA-approved medical
device therapy for the treatment of drug-resistant epilepsy. Over the past two decades, the …

This study aimed to determine how transcutaneous vagus nerve stimulation (tVNS) alters
autonomic nervous activity by comparing the effects of different tVNS frequencies and …

Objective Vagus nerve stimulation (VNS) is a common treatment for medically intractable
epilepsy, but response rates are highly variable, with no preoperative means of identifying …

Despite increasing prevalence and huge personal and societal burden, psychiatric diseases
still lack treatments which can control symptoms for a large fraction of patients. Increasing …

Although vagus nerve stimulation (VNS) is a common procedure, seizure outcomes are
heterogeneous, with few available means to preoperatively identify the ideal surgical …

Highlights• The vagus nerve is a crucial link between gut signals and the brain regulating
various functions such as energy homeostasis, digestion, immune responses, reward …

Vagus nerve stimulation (VNS) is a therapeutic option in drug-resistant epilepsy. VNS leads
to≥ 50% seizure reduction in 50 to 60% of patients, termed" responders". The remaining 40 …